BUSINESSDEUTSCHE WELLE
US probes Germany's 'persistent underpayment' for drugs
The US Trade Representative announced a new probe to determine if Germany is underpaying for pharmaceuticals. The investigation focuses on Germany's 'persistent underpayment' for drugs.
Related Signal
Adjacent reporting
- US launches Germany pharma pricing probe, raising threat of new tariffs
- US launches trade investigation into Germany’s spending on new medicines
- DOJ probes JPMorgan, Citigroup over Iran Supreme Leader Khamenei’s money flows: report
- Paxton probes Lululemon on ‘forever chemicals’
- STAT+: Pharmalittle: We’re reading about U.S. pressuring Germany on drug prices, FDA upheaval and biotech clinical trials, and more
- Southern Poverty Law Center says it’s being investigated by DOJ